EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A MALDI-TOF MS-based multiple detection panel of drug resistance-associated multiple single-nucleotide polymorphisms in Candida tropicalis

Feifei Wan iD, Min Zhang, Jian Guo, Huiping Lin iD, Xiaoguang Zhou, Lixin Wang, Wenjuan Wu iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00764-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Feifei Wan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Candida tropicalis, Polymorphism, Single Nucleotide, Antifungal Agents, Drug Resistance, Fungal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida tropicalis is one of the main causes of invasive candidiasis. Rapid identification of antifungal resistance is crucial for selection of an appropriate antifungal to improve patient outcomes. Mutations at specific loci are strongly correlated with resistance to antifungal agents. In this study, we developed a multi-single-nucleotide polymorphism (SNP) panel to accurately identify 36 mutation sites across seven genes of C. tropicalis that are associated with resistance to azoles and/or echinocandins. Ten isolates were selected to test repeatability, and another 20 isolates of C. tropicalis were selected to validate consistency. Intra-assay and inter-assay repeatability of the panel was 100%, with the loci accuracy being 99.44% (716 of 720). Furthermore, 109 isolates were examined for clinical research, and the most commonly detected mutations were G751A and A866T of UPC2 , A491T of TAC1 , and A395T and C461T of ERG11 . The G751A and A866T mutations of UPC2 as well as the A395T and C461T mutations of ERG11 co-existed. The SNP panel enables identification of specific mutations at critical sites of drug-resistant strains to facilitate the rapid selection of appropriate antifungal agents and efficient monitoring of the regional epidemiological trends of resistance of C. tropicalis . IMPORTANCE C. tropicalis infections pose a growing global public health challenge, with mortality rates approaching 40%. C. tropicalis is one of the top four Candida spp. responsible for candidiasis, particularly in the Asia-Pacific region and Latin America, notably affecting patients with neutropenia and malignancies. The azole resistance rate of C. tropicalis ranges from 0% to 30%. Between 2009 and 2018, the China Hospital Invasive Fungal Surveillance Network reported an increase in fluconazole and voriconazole resistance from 5.7% to ~30%. Although resistance to echinocandins and amphotericin B remains low, multi-resistance to echinocandins and azoles has been observed. Current methods for detecting drug resistance are limited by the long turnaround time of antifungal susceptibility testing, low throughput of Sanger sequence to target resistance mutations, complex data analysis, and high costs of second-generation sequencing. We developed and validated a rapid, high-throughput, and cost-effective panel to detect and monitor drug-resistance mutations of C. tropicalis .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida tropicalisPolymorphism, Single NucleotideAntifungal AgentsDrug Resistance, FungalMicrobial Sensitivity TestsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationHumansCandidiasisMutationEchinocandinsFungal ProteinsAzoles

Stichwörter der Autor:innen

Candida tropicalismatrix-assisted laser desorption/ionization-time of flight mass spectrometrysingle-nucleotide polymorphism

Substanzen

Antifungal AgentsEchinocandinsFungal ProteinsAzoles

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Intelligene Biosystems (Qingdao) Co., Ltd, Qingdao, China.

ORCID-Profile: Feifei Wan, Huiping Lin, Wenjuan Wu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Wan, F., Zhang, M., Guo, J., Lin, H., Zhou, X., Wang, L., & Wu, W. (2025). A MALDI-TOF MS-based multiple detection panel of drug resistance-associated multiple single-nucleotide polymorphisms in Candida tropicalis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00764-24

Vancouver

Wan F, Zhang M, Guo J, Lin H, Zhou X, Wang L, et al. A MALDI-TOF MS-based multiple detection panel of drug resistance-associated multiple single-nucleotide polymorphisms in Candida tropicalis. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00764-24

BibTeX
@article{Wan2025,
  author = {Wan, Feifei and Zhang, Min and Guo, Jian and Lin, Huiping and Zhou, Xiaoguang and Wang, Lixin and Wu, Wenjuan},
  title = {A MALDI-TOF MS-based multiple detection panel of drug resistance-associated multiple single-nucleotide polymorphisms in Candida tropicalis},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00764-24}
}
Kostenlos starten →